Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade

被引:0
|
作者
Daisuke Obinata
Sho Hashimoto
Hideaki Uchida
Ken Nakahara
Tsuyoshi Yoshizawa
Junichi Mochida
Kenya Yamaguchi
Satoru Takahashi
机构
[1] Nihon University School of Medicine,Department of Urology
来源
BMC Urology | / 23卷
关键词
CRPC; Anti-androgens; Prostate cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade
    Obinata, Daisuke
    Hashimoto, Sho
    Uchida, Hideaki
    Nakahara, Ken
    Yoshizawa, Tsuyoshi
    Mochida, Junichi
    Yamaguchi, Kenya
    Takahashi, Satoru
    BMC UROLOGY, 2023, 23 (01)
  • [2] Predicting castration-resistant prostate cancer after combined androgen blockade
    He, Miao
    Liu, Haina
    Cao, Jingyi
    Wang, Qian
    Xu, Haiting
    Wang, Yufeng
    ONCOTARGET, 2017, 8 (62) : 105458 - 105462
  • [3] Azacitidine for castration-resistant prostate cancer progressing on combined androgen blockade
    Sonpavde, G.
    Aparicio, A. M.
    Delaune, R.
    Garbo, L. E.
    Rousey, S. R.
    Weinstein, R. E.
    Williams, A.
    Zhan, F.
    Boehm, K. A.
    Asmar, L.
    Von Hoff, D. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Combined Androgen Blockade Revisited: Emerging Options for the Treatment of Castration-Resistant Prostate Cancer
    Simmons, Matthew N.
    Klein, Eric A.
    UROLOGY, 2009, 73 (04) : 697 - 705
  • [5] Clinical characteristics and outcomes for patients with non‑metastatic castration-resistant prostate cancer
    Peter Arnold
    Maria Cristina Penaloza-Ramos
    Lola Adedokun
    Sarah Rees
    Mohamed Lockhat
    Lisa Spary
    Alan Watkins
    Vincent Gnanapragasam
    Simon J. Crabb
    Scientific Reports, 11
  • [6] Efficacy of androgen signaling blockade in castration-resistant prostate cancer
    Nature Clinical Practice Urology, 2008, 5 (10): : 523 - 524
  • [7] Androgen receptor antagonist Treatment of metastatic castration-resistant prostate cancer Treatment of metastatic breast cancer
    Culig, Zoran
    DRUGS OF THE FUTURE, 2023, 48 (01) : 15 - 21
  • [8] Treatment of metastatic, castration-resistant prostate cancer
    von Amsberg, G.
    Merseburger, A. S.
    UROLOGE, 2020, 59 (06): : 673 - 679
  • [9] Clinical and genomic resistance to second generation androgen blockade in paired biopsies of metastatic castration-resistant prostate cancer
    Han, G. Celine
    Hwang, Justin
    Mullane, Stephanie A.
    Cibulskis, Carrie
    Zhang, Zhenwei
    McKay, Rana R.
    Carter, Scott L.
    Hahn, William C.
    Taplin, Mary-Ellen
    Van Allen, Eliezer M.
    CANCER RESEARCH, 2017, 77
  • [10] Targeting the androgen receptor in metastatic castration-resistant prostate cancer
    Aragon-Ching, Jeanny B.
    FUTURE ONCOLOGY, 2014, 10 (03) : 329 - 332